Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus By Reuters

Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus By Reuters

Upworthy

Published

By Deena Beasley SAN FRANCISCO (Reuters) -An experimental Alzheimer's disease drug from Eisai and Biogen (NASDAQ:BIIB) slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients, according to new data presented on Tuesday. The drug,…

#deenabeasley #alzheimer #eisai #lecanemab #alzheimerdisease #drug #disease #brain #beasley #deena

Full Article